Post-transplantation Lymphoproliferative Disorder (PTLD): In the Liver Transplant Recipient

Abbas, 2020, Post-transplantation lymphoproliferative disorders: current concepts and future therapeutic approaches, World J Transplant, 10, 29, 10.5500/wjt.v10.i2.29 Taylor, 2005, Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation, Crit Rev Oncol Hematol, 56, 155, 10.1016/j.critrevonc.2005.03.015 Tajima, 2021, Post-transplant lymphoproliferative disorders after liver transplantation: a retrospective cohort study including 1954 transplants, Liver Transplant, 27, 1165, 10.1002/lt.26034 Dierickx, 2018, Post-transplantation lymphoproliferative disorders in adults, N Engl J Med, 378, 549, 10.1056/NEJMra1702693 Dierickx, 2013, Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors, Leuk Lymphoma, 54, 2433, 10.3109/10428194.2013.780655 Hsu, 2019, Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan, J Formos Med Assoc, 118, 1537, 10.1016/j.jfma.2018.12.023 Eshraghian, 2017, Post-transplant lymphoproliferative disorder after liver transplantation: incidence, long-term survival and impact of serum tacrolimus level, World J Gastroenterol, 23, 1224, 10.3748/wjg.v23.i7.1224 Nair, 2014, Post liver transplantation lympho proliferative disorder, classical hodgkins lymphoma type—a case report, IJCM, 5, 1142, 10.4236/ijcm.2014.518146 Sharma, 2021, Plasmablastic lymphoma as post transplant lymphoproliferative disorder following liver transplantation, J Liver Transplant, 4 Goli, 2019, Post-transplant epstein–barr virus-related lymphoproliferative disorder: a case report and review of literature, Indian J Med Paediatr Oncol, 40, S120, 10.4103/ijmpo.ijmpo_241_17 Jagirdar, 2018, 14. Post-transplant lymphoproliferative disorder in a post deceased donor liver transplant (DDLT) recipient, J Clinic Experiment Hepatol, 8, S91, 10.1016/j.jceh.2018.06.440 Choudhury Menon, 2021, Late-onset peripheral T-cell lymphoma not otherwise specified in a liver transplant recipient: a rare subtype of posttransplant lymphoproliferative disorder, J Clin Exp Hepatol, 11, 511, 10.1016/j.jceh.2020.09.002 Imanieh, 2022, Post-transplant lymphoproliferative disorder in pediatric liver transplantation: a population-based study from Shiraz, Iran, Shiraz E-Med J [Internet], 23 Kamdar, 2011, Post-transplant lymphoproliferative disease following liver transplantation, Curr Opin Organ Transplant, 16, 274, 10.1097/MOT.0b013e3283465715 Kataoka, 2010, Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature, Leuk Lymphoma, 51, 1494, 10.3109/10428194.2010.492063 Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report | Elsevier Enhanced Reader [Internet]. [cited 2023 Apr 11]. Available from: https://reader.elsevier.com/reader/sd/pii/S1600613522071659?token=C3DFB5FBEFF8347D389037D73280C5C95CAFC33EB9162134716C2C0791A5A8023E12BB63DB608ED556764CA145690D2C&originRegion=eu-west-1&originCreation=20230411131740. Allen, 2002, Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment, Can J Infect Dis, 13, 89 Fujimoto, 2020, Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation: pathogenesis, risk factors and clinical outcomes, Cancers, 12, 328, 10.3390/cancers12020328 Nijland, 2015, Epstein-Barr virus–positive posttransplant lymphoproliferative disease after solid organ transplantation: pathogenesis, clinical manifestations, diagnosis, and management, Transplant Direct, 2, e48, 10.1097/TXD.0000000000000557 Vereide, 2011, Lymphomas differ in their dependence on Epstein-Barr virus, Blood, 117, 1977, 10.1182/blood-2010-05-285791 Gan, 2002, A defective, rearranged epstein-barr virus genome in EBER-negative and EBER-positive hodgkin's disease, Am J Pathol, 160, 781, 10.1016/S0002-9440(10)64900-0 Atallah-Yunes, 2023, Post-transplant lymphoproliferative disorder: update on treatment and novel therapies, Br J Haematol, 201, 383, 10.1111/bjh.18763 Dayton, 2011, Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients, J Heart Lung Transplant, 30, 420, 10.1016/j.healun.2010.10.004 Haddad, 2006, Cyclosporin versus tacrolimus for liver transplanted patients, Cochrane Database Syst Rev, 2006, CD005161 Jain, 2002, Posttransplant lymphoproliferative disorders in liver transplantation, Ann Surg, 236, 429, 10.1097/00000658-200210000-00005 Mumtaz, 2015, Post-transplant lymphoproliferative disorder in liver transplant recipients: characteristics, management and outcome from a single-centre experience with >1000 liver transplantations, Chin J Gastroenterol Hepatol, 29, 417 Gupta, 2020, Post transplant lymphoproliferative disorder, Indian J Hematol Blood Transfus, 36, 229, 10.1007/s12288-019-01182-x Marie, 2020, Posttransplant lymphoproliferative disorder in children: a 360-degree perspective, Radiographics, 40, 241, 10.1148/rg.2020190103 Allen, 2019, Post-transplant lymphoproliferative disorders, epstein-barr virus infection, and disease in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice, Clin Transplant, 33, 10.1111/ctr.13652 Lee, 2005, Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients, Am J Transplant, 5, 2222, 10.1111/j.1600-6143.2005.01002.x showPdf.pdf [Internet]. [cited 2023 Feb 28]. Available from: https://www.amjtransplant.org/action/showPdf?pii=S1600-6135%2822%2924907-7. Wagner, 2001, Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction, Transplantation, 72, 1012, 10.1097/00007890-200109270-00006 Chen, 2019, Roles of Epstein–Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation, J Formos Med Assoc, 118, 1362, 10.1016/j.jfma.2018.12.007 Parker, 2010, Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients – BCSH and BTS Guidelines, Br J Haematol, 149, 675, 10.1111/j.1365-2141.2010.08161.x Allen, 2013, Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation, Am J Transplant, 13, 107, 10.1111/ajt.12104 Schaffer, 2011, Surveillance of epstein-barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications, Liver Transplant, 17, 1420, 10.1002/lt.22406 2016, Liver transplantation, J Hepatol, 64, 433, 10.1016/j.jhep.2015.10.006 Tsai, 2002, Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients, Am J Transplant, 2, 946, 10.1034/j.1600-6143.2002.21011.x Shah, 2021, Front-line management of post-transplantation lymphoproliferative disorder in adult solid organ recipient patients — a British Society for Haematology Guideline, Br J Haematol, 193, 727, 10.1111/bjh.17421 Jain, 2005, Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center, Transplantation, 80, 1692, 10.1097/01.tp.0000185570.41571.df Penn, 1995, Central nervous system lymphomas in organ allograft recipients, Transplantation, 59, 240, 10.1097/00007890-199501000-00016 Taj, 2008, Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children, Br J Haematol, 140, 191, 10.1111/j.1365-2141.2007.06896.x Comoli, 2002, Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication, Blood, 99, 2592, 10.1182/blood.V99.7.2592 Haque, 2007, Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial, Blood, 110, 1123, 10.1182/blood-2006-12-063008 Kazi, 2019, Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease, Haematologica, 104, e356, 10.3324/haematol.2018.207548 Eyre, 2021, Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT, Bone Marrow Transplant, 56, 2118, 10.1038/s41409-021-01270-5 Kremers, 2006, Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival, Am J Transplant, 6, 1017, 10.1111/j.1600-6143.2006.01294.x Rubio-Manzanares Dorado, 2017, Post-transplant lymphoproliferative disease in liver transplant recipients, Rev Esp Enferm Dig [Internet], 109 Marino, 2010